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Non-Hodgkin lymphoma (NHL) belongs to
the types of malignant diseases that have
shown the largest increasing incidence in
Sweden and in other Western countries during
the second half of the 20th century. According
to statistics in the National Swedish Cancer
Registry, the yearly age-standardized incidence
increased significantly for NHL during
1971–1990, an average of 3.2% for men and
3.1% for women (National Board of Health
and Welfare 1993). The corresponding ﬁgures
for 1991–2000 were –0.8% and –0.2%,
respectively (National Board of Health and
Welfare 2002a). A clear change of the inci-
dence was seen about 1990 (Figure 1).
In the 1990s, the increasing incidence of
NHL also leveled off in Denmark (study period
1989–1998; Danish Cancer Registry 2002)
and in Finland (study period 1954–2000;
Finnish Cancer Registry 2003), but not in
Norway (1955–2000; Cancer Registry of
Norway 2003) or in the United Kingdom
(1971–1997; National Statistics 2001).
The Surveillance, Epidemiology, and End
Results (SEER) Program (2003) of the
National Cancer Institute is the most authori-
tative source of information on cancer inci-
dence in the United States. Data have been
collected from certain states beginning in
1973; 1999 is currently the last year with
available data. The annual percentage change,
based on rates that are age adjusted to the
2000 U.S. standard population by 5-year age
groups, for all races and both sexes, was
+3.6% (p < 0.05) during 1973–1990, +1.6%
during 1990–1995, and –0.9% during
1995–1999. However, the declining incidence
was seen only in men, although a declining
mortality was seen in both sexes during
1990–1995. The increasing incidence of
NHL since 1973 clearly leveled off during the
1990s (Ries et al. 2002).
Are there any etiologic agents that can be
associated with the changing incidence of
NHL in Sweden and other countries? The
etiology of NHL is only partly known.
Immunosuppression, both acquired and
hereditary, has been described to increase the
risk, for example, of drug-induced immuno-
suppression after organ transplantation, infec-
tion with human immunodeficiency virus
(HIV), and certain autoimmune diseases.
Also, viruses, especially Epstein-Barr virus
(EBV), have been postulated to be of etio-
logic signiﬁcance (Evans and Mueller 1990).
These risk factors cannot explain the
observed changes of the incidence of NHL,
however. The initial large increase of the inci-
dence and later stabilizing or even decreasing
incidence might be explained by one or several
environmental agents with decreasing expo-
sure of the population (e.g., because of regula-
tion). Because the tumor-induction period in
lymphomagenesis, as for other malignant dis-
eases, varies from years to decades, regulation
of such risk factors would probably have
occurred during the 1970s and 1980s.
In this article, we discuss results from our
studies and those of others since the late
1970s about the association between some
chemical compounds and the risk for NHL.
Our hypothesis is that changes in exposure to
these compounds may at least partly explain
the observed changes of NHL incidence, with
Sweden as one example. Our intention is not
to give a complete review of the etiology of
NHL (for review, see, e.g., Hardell and
Axelson 1998; Hardell et al. 2003). Risk esti-
mates and exposure frequencies in our studies
enable calculation of the attributable fraction,
that is, the proportion of cases that can be
attributed to the particular exposure. This
was calculated as the exposed case fraction
multiplied by [(OR – 1)/OR], where OR is
the odds ratio.
Phenoxyacetic Acids and
Chlorophenols
Phenoxyacetic acids were synthesized during
World War II and were widely and increas-
ingly used as herbicides (including on hard-
wood trees) from the early 1950s both in
Sweden and in other countries. The chemi-
cally related chlorophenols were primarily
used as impregnating agents.
Our ﬁrst study on risk factors for NHL in
men, which was initiated by a clinical obser-
vation (Hardell 1979), was published in
1981. We found a significant association
between exposure to phenoxyacetic acids and
chlorophenols and malignant lymphoma,
both NHL and Hodgkin disease (Hardell et
al. 1981). The results for NHL were also
published separately (Hardell et al. 1994) and
have been replicated by other research groups
both in Sweden (Persson et al. 1989) and in
other countries (Zahm et al. 1990; for
updated review, see Hardell et al. 2003).
Our ﬁrst investigation on NHL included
patients diagnosed during 1974–1978 and
mainly assessed exposures from the late 1940s
and later (Hardell et al. 1981, 1994). The
phenoxyacetic acids 2,4-dichlorophenoxy-
acetic acid (2,4-D) and 2,4,5-trichloro-
phenoxyacetic acid (2,4,5-T) constituted
Hormoslyr (Gullvik, Sweden), one of the
most widely used pesticides in Sweden during
that period. 2,4,5-T was contaminated with
dioxins during the production. Most haz-
ardous among these dioxins was 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), one of
the most toxic chemicals in the world and
now classiﬁed as a group I human carcinogen
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Cancer (IARC 1997a). Agent Orange, as used
during the Vietnam War, contained the same
phenoxyacetic acids as Hormoslyr, and thus
the same contaminations. In 2,4-D, lower
chlorinated dioxins occurred.
The use of Hormoslyr was prohibited in
Sweden in 1977, and chlorophenols were
prohibited in January 1978. In our ﬁrst study
(Hardell et al. 1981, 1994), the attributable
fraction for Hormoslyr was 13% and that for
chlorophenols was 26%. A substantially lower
attributable fraction of 3.0% for phenoxy-
acetic acids was calculated in a study on men
and women in central Sweden (Persson et al.
1989), but a small number of subjects in the
study had been exposed to chlorophenols. 
Our next epidemiologic study on NHL
(Hardell and Eriksson 1999) encompassed
1987–1990 and was further analyzed in com-
bination with a study on hairy cell leukemia, a
subgroup of NHL, for 1987–1992 (Hardell et
al. 2002). Only men were included in these
studies. Lower ORs for exposure to 2,4-D and
2,4,5-T (Hormoslyr) were obtained. The risk
was highest with a latency period of 10–20
years and decreased with longer tumor induc-
tion periods (Hardell et al. 2002). The attrib-
utable fraction calculated for Hormoslyr was
3.0%, and that for chlorophenols was 3.5%.
In a study from Kansas (USA), the attrib-
utable fraction for the phenoxyacetic acids
was calculated to be 7.7% (Hoar et al. 1986),
and for 2,4-D in eastern Nebraska (USA), it
was 7.1% (Hoar Zahm et al. 1990).
Organic Solvents
In our ﬁrst study, the attributable fraction for
NHL was calculated to be 25% for organic
solvents (Hardell et al. 1981, 1994). In our
next study (Hardell and Eriksson 1999), no
significantly increased risk was found. One
explanation might be that newer organic 
solvents are chemically different from earlier
ones and are handled under better hygienic
conditions than before (Axelson and Hogstedt
1994). In another Swedish study with expo-
sures during the same period (Persson et al.
1989), the attributable fraction was calculated
to be 16%.
Persistent Organic
Environmental Pollutants
In a number of studies, we have measured
concentrations of certain persistent organic
pollutants in patients with NHL, both males
and females, and compared these with con-
centrations from population controls (Hardell
et al. 1996, 2001a). These results have been
corroborated in other studies (Rothman et al.
1997). We found an interaction between
polychlorinated biphenyls (PCBs), and EBV
antigen, with an attributable fraction of 25%.
The attributable fraction was of the same
magnitude for hexachlorobenzene and chlor-
danes. Also, for dioxins calculated as toxic
equivalents, we found a similar attributable
fraction (Hardell et al. 2001b). All samples
(blood or adipose tissue) in our studies were
taken before patients received any treatment
for the disease. It should also be pointed out
that the concentrations of these persistent
organic pollutants have substantially declined
in the environment and population in
Sweden since the 1980s (Bernes and Naylor
1998; Norén and Merionyté 2000).
Certainly, the interaction between EBV
and chemical exposures in the etiology of
NHL is still hypothetical. However, polyclonal
B-cell proliferation is often seen among organ
transplantation recipients. Immunosuppression
in these patients may lead to loss of cell-medi-
ated immune control of reactivated EBV as
part of this process, and clonal EBV has been
found in posttransplantation EBV (Patton et
al. 1990). A Finnish cohort of subjects with
elevated EBV antibodies was found to have an
increased risk for malignant lymphoma
(Lehtinen et al. 1993). EBV has been classiﬁed
by IARC as a group I (sufficient evidence)
human carcinogen (IARC 1997b).
Human Immunodeﬁciency
Virus
HIV has been shown to be a risk factor for
NHL, and it has been estimated that the
probability of developing NHL is 29% after
36 months of antiviral therapy (Pluda et al.
1993). However, in Sweden the prevalence of
HIV is low and has been rather stable during
the 1990s; 335 cases were reported in 1990,
which increased to 390 in 1993 and declined
to 277 in 2001 (National Board of Health
and Welfare 2002b). Thus, these numbers do
not explain the change of NHL incidence
during the 1990s in Sweden.
Discussion
Of interest is that the leveling off of the inci-
dence of NHL during the 1990s has also
occurred in countries other than Sweden. Data
from the United States, Finland, and Denmark
show a similar trend. However, for Norway
and the United Kingdom, no such clear pat-
tern has yet emerged. These data might reﬂect
changes of common risk factors in different
populations. Different chemicals that have
been widely used in the Western World might
constitute such factors, among them, persistent
organic pollutants.
Most of the chemicals discussed in this
article were introduced during or shortly after
World War II. Exposure of the population
increased until restrictions during the 1970s
for Hormoslyr, chlorophenols, and PCBs,
among others. The highest exposure occurred
during the 1970s for persistent organic pollu-
tants such as dioxins, chlorophenols, and
PCBs (Bernes and Naylor 1998). After that,
the concentrations in the environment and
thus also in the food chain have declined,
although the rate has leveled off during the
1990s. It should also be emphasized that
work practices for herbicides in general have
improved over the years with the use of pro-
tective equipment. This may also contribute
to a lower risk for NHL.
In previous studies organic solvents have
been shown to increase the risk for hemato-
poietic malignancies. Also for these chemicals,
improvement in exposure conditions has
occurred, such as bans of some organic solvents,
cleaner and more water-based products, and
better hygienic conditions during handling.
Immunosuppression is an established risk
factor for NHL. Most of the chemicals
described here have immunotoxic properties,
as discussed in the publications cited. After
organ transplantation, a very high risk for
NHL has been found, and the risk increase is
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Figure 1. Age-standardized incidence per 100,000 of NHL (ICD-7 code 200) according to the Swedish Cancer
Registry for all ages in 2000 (National Board of Health and Welfare 2002a).
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largest during the ﬁrst years after transplanta-
tion. Interactions between immunosuppres-
sion and EBV have been discussed as one
explanation (Newstead 1998). Our results
showing the highest risk for exposure to phe-
noxyacetic acids and chlorophenols with a
rather short latency period (Hardell et al.
2002) may ﬁt with the ﬁndings among organ
transplantation patients. The finding of an
interaction between chemicals and EBV might
be of interest in this context (Hardell et al.
2001a, 2001b; Nordström et al. 1999, 2002).
Exposure to the risk factors discussed here,
such as phenoxyacetic acids (e.g., Hormoslyr),
chlorophenols, and organic solvents, has mainly
been occupational. There are also geographic
differences in exposure frequency in Sweden. If
the lowest calculated attributable fraction of 3%
is used for phenoxyacetic acids, 30 patients out
of 1,000 with NHL would have avoided the
disease without these herbicides on the market.
Similarly, the number of patients in Sweden
attributed to exposure to chlorophenols and
organic solvents may be calculated.
Regarding persistent organic pollutants,
the situation is quite different because the
whole population is exposed, mainly thor-
ough the food chain (e.g., fatty ﬁsh and dairy
products). Probably, these chemicals have
been of larger etiologic significance in the
whole population than have pesticides and
organic solvents. An attributable fraction of
25% contributes to 250 of 1,000 cases diag-
nosed yearly. However, in Sweden, the inci-
dence of NHL has been higher in men than
in women, indicating that occupational risk
factors might be of some significance.
Furthermore, of interest is the fact that the
incidence has declined during the 1990s
somewhat more in men than in women and,
in the United States, only in men thus far.
Finally, we must emphasize that any single
subject may be exposed to several of the agents
discussed here, with the potential for interac-
tion in lymphomagenesis. This of course com-
plicates the calculation of the attributable
fraction for a single agent. In this article we do
not cover all aspects of lymphomagenesis, but
we show that the ban of carcinogenic chemi-
cals may be one explanation for the decline in
incidence within a rather short time, although
the quantitative effect of an individual agent
cannot be deﬁned.
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